Literature DB >> 28390745

Effect of improved door-to-balloon time on clinical outcomes in patients with ST segment elevation myocardial infarction.

Wei-Chieh Lee1, Hsiu-Yu Fang1, Huang-Chung Chen1, Shu-Kai Hsueh1, Chien-Jen Chen1, Cheng-Hsu Yang1, Hon-Kan Yip1, Chi-Ling Hang1, Chiung-Jen Wu1, Chih-Yuan Fang2.   

Abstract

OBJECTIVE: Few studies have focused on the effects of an improved door-to-balloon time on clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study was to explore the effect of improving door-to-balloon time on prognosis and to identify major predictors of mortality.
METHODS: From January 2005 to December 2014, 1751 patients experienced STEMI and received primary percutaneous intervention in our hospital. During a 10-year period, the patients were divided into two groups according to the time period. Since mid-2009, shortening door-to-balloon time has been an important concern of health care. As a result of targeted efforts, as of January 2010, door-to-balloon time shortened significantly. In our study, a total 853 patients were in group 1 during January 2005 to December 2009, and a total 898 patients were in group 2 during January 2010 to December 2014.
RESULTS: The incidence of major adverse cardiac cerebral events (26.7% vs. 23.2%; p=0.120), the incidence of cardiovascular mortality (9.3% vs. 8.8%; p=0.741), and the incidence of all-cause mortality (12.6% vs. 12.2%; p=0.798) were similar between the two groups. The incidence of target vessel revascularization significantly decreased in group 2 (17.8% vs. 12.6%; p=0.008). However, the incidence of stroke increased in group 2 (1.8% vs. 3.6%; p=0.034).
CONCLUSION: Improving door-to-balloon time could not improve 1-year cardiovascular mortality whether low-risk or high-risk patients. The improvement in the door-balloon time does not improve outcomes studied, probably because it is not accompanied by a reduction in total reperfusion time, which means from onset of symptoms to reperfusion.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Door-to-balloon time; Prognostic factors; ST segment elevation myocardial infarction

Mesh:

Year:  2017        PMID: 28390745     DOI: 10.1016/j.ijcard.2017.02.156

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Real-world, feasibility study to investigate the use of a multidisciplinary app (Pulsara) to improve prehospital communication and timelines for acute stroke/STEMI care.

Authors:  Chris F Bladin; Kathleen L Bagot; Michelle Vu; Joosup Kim; Stephen Bernard; Karen Smith; Grant Hocking; Tessa Coupland; Debra Pearce; Diane Badcock; Marc Budge; Voltaire Nadurata; Wayne Pearce; Howard Hall; Ben Kelly; Angie Spencer; Pauline Chapman; Ernesto Oqueli; Ramesh Sahathevan; Thomas Kraemer; Casey Hair; Dion Stub; Dominique A Cadilhac
Journal:  BMJ Open       Date:  2022-07-18       Impact factor: 3.006

2.  Community-Based Pre-Hospital Electrocardiogram Transmission Program for Reducing Systemic Time Delay in Acute ST-Segment Elevation Myocardial Infarction.

Authors:  Kyungil Park; Jong Sung Park; Young Rak Cho; Tae Ho Park; Moo Hyun Kim; Tae Hyun Yang; Doo Il Kim; Jung Hwan Kim; Yong Hwan Lee; Dong Won Lee; Jeongkee Seo; Geun Young Lee; Young Dae Kim
Journal:  Korean Circ J       Date:  2020-08       Impact factor: 3.243

3.  Association between the Door-to-balloon Time and Mid-term Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction.

Authors:  Takunori Tsukui; Kenichi Sakakura; Yousuke Taniguchi; Kei Yamamoto; Masaru Seguchi; Hiroshi Wada; Shin-Ichi Momomura; Hideo Fujita
Journal:  Intern Med       Date:  2020-07-01       Impact factor: 1.271

4.  Prognostic Implications of the Admission Cardiac Troponin I Levels and Door-to-Balloon Time on Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.

Authors:  Longguo Zhao; Minglong Xin; Xianji Piao; Shengming Zhang; Yanglong Li; Xian Wu Cheng
Journal:  Ther Clin Risk Manag       Date:  2022-01-07       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.